FHR3 Blocks C3d-Mediated Coactivation of Human B Cells
暂无分享,去创建一个
[1] A. Goldman,et al. The Major Autoantibody Epitope on Factor H in Atypical Hemolytic Uremic Syndrome Is Structurally Different from Its Homologous Site in Factor H-related Protein 1, Supporting a Novel Model for Induction of Autoimmunity in This Disease* , 2015, The Journal of Biological Chemistry.
[2] P. Zipfel,et al. New insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseases. , 2014, Molecular immunology.
[3] V. Holers. Complement and its receptors: new insights into human disease. , 2014, Annual review of immunology.
[4] C. Skerka,et al. Complement factor H related proteins (CFHRs). , 2013, Molecular immunology.
[5] P. Barlow,et al. Functional anatomy of complement factor H. , 2013, Biochemistry.
[6] L. Rostaing,et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[7] A. Goldman,et al. Microbes Bind Complement Inhibitor Factor H via a Common Site , 2013, PLoS pathogens.
[8] E. Goicoechea de Jorge,et al. Dimerization of complement factor H-related proteins modulates complement activation in vivo , 2013, Proceedings of the National Academy of Sciences.
[9] P. Sánchez-Corral,et al. Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations , 2012, International journal of immunogenetics.
[10] D. Svergun,et al. Structural Analysis of the C-Terminal Region (Modules 18–20) of Complement Regulator Factor H (FH) , 2012, PloS one.
[11] R. Cantor,et al. Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility , 2011, PLoS genetics.
[12] Loreto Gesualdo,et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy , 2011, Nature Genetics.
[13] A. Goldman,et al. Dual interaction of factor H with C3d and glycosaminoglycans in host–nonhost discrimination by complement , 2011, Proceedings of the National Academy of Sciences.
[14] C. Keilhauer,et al. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). , 2010, Human molecular genetics.
[15] John D Lambris,et al. Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.
[16] D. Fearon,et al. Pillars Article: CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science, 1992. 256: 105-107. , 2010, Journal of immunology.
[17] C. Sautès-Fridman,et al. Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome. , 2010, Kidney international.
[18] P. Barlow,et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. , 2010, Blood.
[19] U. Schlötzer-Schrehardt,et al. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. , 2009, Blood.
[20] P. Zipfel,et al. Complement regulators and inhibitory proteins , 2009, Nature Reviews Immunology.
[21] Francesco Saverio Tedesco,et al. Complement in human diseases: Lessons from complement deficiencies. , 2009, Molecular immunology.
[22] D. Ricklin,et al. Cutting Edge: Members of the Staphylococcus aureus Extracellular Fibrinogen-Binding Protein Family Inhibit the Interaction of C3d with Complement Receptor 21 , 2008, The Journal of Immunology.
[23] J. Richter,et al. The Staphylococcus aureus Protein Sbi Acts as a Complement Inhibitor and Forms a Tripartite Complex with Host Complement Factor H and C3b , 2008, PLoS pathogens.
[24] P. Zipfel,et al. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. , 2008, Blood.
[25] M. Oppermann,et al. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. , 2007, Blood.
[26] J. Goodship,et al. Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome , 2007, PLoS genetics.
[27] E. Bergmann-Leitner,et al. Complement 3d: from molecular adjuvant to target of immune escape mechanisms. , 2006, Clinical Immunology.
[28] N. Orr,et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration , 2006, Nature Genetics.
[29] W. Fridman,et al. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. , 2005, Journal of the American Society of Nephrology : JASN.
[30] S. Pierce,et al. The Role of the CD19/CD21 Complex in B Cell Processing and Presentation of Complement-Tagged Antigens , 2001, The Journal of Immunology.
[31] N. Brot,et al. C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response , 2000, The Journal of experimental medicine.
[32] S. Meri,et al. Functional properties of complement factor H‐related proteins FHR‐3 and FHR‐4: binding to the C3d region of C3b and differential regulation by heparin , 1999, FEBS letters.
[33] M. Dierich,et al. Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21). , 1998, Journal of immunology.
[34] I. Melchers,et al. Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoprotein. , 1998, International immunology.
[35] M. Cooper,et al. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[36] E. Kremmer,et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. , 1996, Journal of immunology.
[37] R. Karr,et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Ahearn,et al. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. , 1996, Immunity.
[39] V. Vetvicka,et al. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. , 1994, Journal of immunology.
[40] P. Zipfel,et al. A novel short consensus repeat-containing molecule is related to human complement factor H. , 1993, The Journal of biological chemistry.
[41] P. Zipfel,et al. Two additional human serum proteins structurally related to complement factor H. Evidence for a family of factor H-related genes. , 1992, Journal of immunology.
[42] D. Fearon,et al. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. , 2000, Annual review of immunology.
[43] N. Brot,et al. C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response: Implications for Systemic Autoimmunity , 2000 .